Tumor drug distribution and target engagement of MLN9708, an investigational proteasome inhibitor, in patients with advanced solid tumors.
Alessandra Di Bacco
Employment or Leadership Position - Millennium; Millennium
Allison Berger
Employment or Leadership Position - Millennium
Neeraj Gupta
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
Feng Gao
Employment or Leadership Position - Millennium
Stephen Blakemore
Employment or Leadership Position - Millennium
Mark Qian
Employment or Leadership Position - Millennium
Susan Chen
Employment or Leadership Position - Millennium
Bradley Stringer
Employment or Leadership Position - Millennium
Yu Yang
Employment or Leadership Position - Millennium
Ray Liu
Employment or Leadership Position - Millennium
Stephen Tirrell
Employment or Leadership Position - Millennium
Doug Bowman
Employment or Leadership Position - Millennium
David C. Smith
Research Funding - Millennium
Daniel Sullivan
No relevant relationships to disclose
Jeffrey R. Infante
No relevant relationships to disclose
John S. Kauh
No relevant relationships to disclose
Lillian L. Siu
Research Funding - Millennium
Gordana Vlahovic
Consultant or Advisory Role - Genentech
John A. Thompson
Research Funding - Millennium
Thea Kalebic
Employment or Leadership Position - Millennium